Loading clinical trials...
Loading clinical trials...
A Phase 1b, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of FLQ-101 in Premature Neonates at High Risk of Developing ROP
Conditions
Interventions
FLQ-101
Locations
1
United States
St. David's Medical Center
Austin, Texas, United States
Start Date
April 3, 2026
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
April 21, 2026
NCT06694103
NCT04015180
NCT07123948
NCT07112430
NCT06775353
NCT06649513
Lead Sponsor
FELIQS INC.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions